These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 28263022)
1. The importance of patient-centred care to overcome barriers in the management of actinic keratosis. Cerio R J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022 [TBL] [Abstract][Full Text] [Related]
3. The importance of treating the field in actinic keratosis. Stockfleth E J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021 [TBL] [Abstract][Full Text] [Related]
4. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach. Lee AD; Jorizzo JL Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577 [TBL] [Abstract][Full Text] [Related]
5. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies. Berman B; Cohen DE; Amini S Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095 [TBL] [Abstract][Full Text] [Related]
6. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Berman B; Cohen DE; Amini S Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439 [TBL] [Abstract][Full Text] [Related]
7. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics. Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415 [TBL] [Abstract][Full Text] [Related]
8. Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis. Peris K; Neri L; Fargnoli MC; Pellacani G G Ital Dermatol Venereol; 2014 Apr; 149(2):193-8. PubMed ID: 24819639 [TBL] [Abstract][Full Text] [Related]
9. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy. Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638 [TBL] [Abstract][Full Text] [Related]
10. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy. Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G; J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789 [TBL] [Abstract][Full Text] [Related]
11. Swiss clinical practice guidelines on field cancerization of the skin. Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459 [TBL] [Abstract][Full Text] [Related]
12. Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis. Berry K; Butt M; Kirby JS JAMA Dermatol; 2017 May; 153(5):421-426. PubMed ID: 28114674 [TBL] [Abstract][Full Text] [Related]
13. Topical management of actinic keratosis and field cancerisation. Stockfleth E G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950 [TBL] [Abstract][Full Text] [Related]
14. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Feldman SR; Fleischer AB Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496 [TBL] [Abstract][Full Text] [Related]
15. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. Philipp-Dormston WG Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215 [TBL] [Abstract][Full Text] [Related]
16. New and current preventive treatment options in actinic keratosis. Arenberger P; Arenbergerova M J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940 [TBL] [Abstract][Full Text] [Related]
17. Actinic keratosis: Current challenges and unanswered questions. Malvehy J; Stratigos AJ; Bagot M; Stockfleth E; Ezzedine K; Delarue A J Eur Acad Dermatol Venereol; 2024 Jul; 38 Suppl 5():3-11. PubMed ID: 38923589 [TBL] [Abstract][Full Text] [Related]
18. [Beyond actinic keratoses: Field cancerization of the skin]. Reygagne P; Rostain G Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819 [TBL] [Abstract][Full Text] [Related]
19. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361 [TBL] [Abstract][Full Text] [Related]
20. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression. Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM; J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]